Accurately diagnose your patients with tick-borne diseases sooner
Get the insights you need with a comprehensive menu of reliable tick-borne disease testing from Quest Diagnostics
In recent years, the number of northeastern US counties identified as having a high incidence of Lyme disease has increased more than 320%.1
Testing from Quest can help you make accurate tick-borne disease diagnoses
With more than 30 tick-borne disease tests and panels, including both molecular and serologic testing, Quest can help you make timely, differential diagnoses.
Testing helps support accurate, differential diagnoses
Diagnosis of tick-borne disease is primarily based on:
- History of exposure to an area where ticks are endemic
- Clinical presentation
Because tick-related illnesses present similar signs and symptoms, laboratory testing can help confirm a clinical diagnosis. Tests include:
- Polymerase chain reaction (PCR)-based assays
- Serologic techniques
- Microscopic visualization
- Tick identification
1. Kugeler KJ, Farley GM, Forrester JD, et al. Geographic Distribution and Expansion of Human Lyme Disease, United States. Emerging Infectious Diseases. 2015;21(8):1455-1457.
Quest, Quest Diagnostics, the associated logo, Nichols Institute, and all associated Quest Diagnostics marks are the registered trademarks of Quest Diagnostics. All third-party marks — ® and ™ — are the property of their respective owners. © 2000-2018 Quest Diagnostics Incorporated. All rights reserved.